Mr Thomas Hinchliffe KC KC > Three New Square Intellectual Property > London, England > Barrister Profile

Three New Square Intellectual Property
Three New Square
3 NEW SQUARE, LINCOLN'S INN
LONDON
WC2A 3RS
England

Position

All aspects of contentious intellectual property, with a particular emphasis on patent litigation in the pharmaceutical, biotechnology and mobile telephony fields. Recent notable cases include: Advanced cell Diagnostics v Molecular Instruments [2024] (DNA and RNA detection techniques), Bayer IP v Aspire & Others [2024] (interim injunctions, launch of generic pharmaceutical products); Nokia v Oppo (2022) (LTE RACH preamble sequences); Optis v Apple [2022] (LTE PUCCH multiplexing); Alcon v AMO [2021] (laser cataract surgery); Teva v Janssen [2021] (SPC, prodrugs); InterDigital v Lenovo [2021] (4G – two trials); Illumina v MGI [2020] (DNA sequencing, fluorescence); IPCom v HTC [2020] (patent damages); Merck Sharp & Dohme v Wyeth [2020] (pneumococcal vaccines); Conversant v Huawei & ZTE (3G/4G mobile phones; FRAND inquiries); Aspire/Accord v Allergan [2019] (glaucoma, penetration enhancers); Emson v Hozelock [2020] & [2019] (expandable hosepipes); Philips v Asus [2019] & [2018] (mobile phones, UMTS, HSDPA, power control); Merck v The Comptroller C-567/16 [2017] (CJEU, SPC; marketing authorisations); Illumina v Premaitha [2017] (patents, ante-natal testing); Merck v Teva [2017] (SPC, HIV drugs), Novartis v Actavis [2016] (Alzheimer’s drugs); Lilly v Actavis [2016] (male erectile dysfunction); Hospira v Cubist [2016] & [2017] (antibiotics); Unwired Planet v Samsung [2016] (UMTS mobile telephone); Merck v Ono [2015] (anti-cancer antibiotics); Merck v Sigma C-539/13; [2013] (CJEU, parallel imports, Specific Mechanism); Philips v Nintendo [2014] (Nintendo Wii, motion controllers); AGA v Occlutech [2014] (medical devices, atrial septal occluders);; Mylan v Yeda [2014] (multiple sclerosis); Perini v PCMC [2012] damages inquiry).

Career

Called 1997, took silk 2016; Middle Temple; Editor 18th, 19th and 20th Editions of ‘Terrell on the Law of Patents’, contributor to the 15th and 16th editions.

Memberships

Intellectual Property Bar Association; Chancery Bar Association.

Education

Brasenose College, Oxford (1995 MA Chemistry, first); City University (1996 Diploma in Law, Distinction); Inns of Court School of Law (1997, top of year, Outstanding, Scarman scholarship).

 

Lawyer Rankings

London Bar > Intellectual property

(Leading Silks)Ranked: Tier 2

Thomas Hinchliffe KC – Three New Square ‘Thomas gets on board a matter very speedily, provides astute advice, and is always ready to roll his sleeves up and deal with matters strategically and expeditiously. His advocacy is powerful.’

IP powerhouse’ Three New Square is home to a number of active barristers including Guy Burkill KC, who boasts particular expertise in the patent litigation arena, especially in cases surrounding the telecoms and technology industries. Douglas Campbell KC is another notable silk, and he practices in patent, trade mark, and confidential information cases. Thomas Hinchliffe KC also specialises in patent-related work, specifically in cases involving the pharmaceutical, biotechnological and computing sectors. Tom Mitcheson KC is another active team member who has been instructed on a large volume of leading and high-profile cases. Turning to the juniors, Denise McFarland has a thriving trade marks practice, and Tim Austen regularly appears before a range of courts for his clients, including the Patents Court, the Intellectual Property Enterprise Court, the Court of Appeal, and the Commercial Court, as well as the EPO.

London Bar > IT and telecoms: projects and services

(Leading Silks)Ranked: Tier 3

Thomas Hinchliffe KCThree New Square ‘Tom really cares about the cases he is involved in and is very active in working alongside the solicitor team to get into the detail and to forge the case theory from an early stage. His advocacy reflects his grasp of the case and the subject area and he is able to keep the experts honest through his cross examination.’